Inceptor binds to and directs insulin towards lysosomal degradation in β cells

Nat Metab. 2024 Dec;6(12):2374-2390. doi: 10.1038/s42255-024-01164-y. Epub 2024 Nov 25.

Abstract

Blunted first-phase insulin secretion and insulin deficiency are indicators of β cell dysfunction and diabetes manifestation. Therefore, insights into molecular mechanisms that regulate insulin homeostasis might provide entry sites to replenish insulin content and restore β cell function. Here, we identify the insulin inhibitory receptor (inceptor; encoded by the gene IIR/ELAPOR1) as an insulin-binding receptor that regulates insulin stores by lysosomal degradation. Using human induced pluripotent stem cell (SC)-derived islets, we show that IIR knockout (KO) results in enhanced SC β cell differentiation and survival. Strikingly, extended in vitro culture of IIR KO SC β cells leads to greatly increased insulin content and glucose-stimulated insulin secretion (GSIS). We find that inceptor localizes to clathrin-coated vesicles close to the plasma membrane and in the trans-Golgi network as well as in secretory granules, where it acts as a sorting receptor to direct proinsulin and insulin towards lysosomal degradation. Targeting inceptor using a monoclonal antibody increases proinsulin and insulin content and improves SC β cell GSIS. Altogether, our findings reveal the basic mechanisms of β cell insulin turnover and identify inceptor as an insulin degradation receptor.

MeSH terms

  • Animals
  • Cell Differentiation
  • Glucose / metabolism
  • Humans
  • Induced Pluripotent Stem Cells* / metabolism
  • Insulin Secretion
  • Insulin* / metabolism
  • Insulin-Secreting Cells* / metabolism
  • Lysosomes* / metabolism
  • Proinsulin / metabolism
  • Protein Binding
  • Proteolysis
  • Receptor, Insulin / metabolism
  • trans-Golgi Network / metabolism

Substances

  • Insulin
  • Receptor, Insulin
  • Glucose
  • Proinsulin